Moreover, blood As concentrations, as well as serum levels of S100B protein which is a biomarker for blood-brain barrier (BBB) dysfunction, were found to be elevated in RRMS patients [28]. This evidence concerns the gene S100B and relapsing-remitting multiple sclerosis.